72606-042Level 3
AVTOZMA (tocilizumab)
**Product type:** Human Prescription Drug
**Active ingredient:** TOCILIZUMAB
**Strength:** 80 mg/4mL
**Dosage form:** Injection, Solution
**Route:** Intravenous
**Labeler:** CELLTRION USA, Inc.
**Marketing category:** BLA (BLA761420)
**Pharmacologic class:** Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]
GET
/api/v1/systems/ndc_fda/nodes/72606-042Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.